Biologists unravel drug-resistance mechanism in tumor cells
Targeting the RNA-binding protein that promotes resistance could lead to better cancer therapies.
Targeting the RNA-binding protein that promotes resistance could lead to better cancer therapies.
New approach could aid in treatment of inflammatory bowel disease.
Researchers use engineered viruses to provide quantum-based enhancement of energy transport.
Yeast protein could offer clues to how Alzheimer’s plaques form in the brain.
New study reveals the soft palate is a key site for evolution of airborne transmissibility.
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
Researchers discover that aspartate is a limiter of cell proliferation.
A pH-responsive polymer gel could create swallowable devices, including capsules for ultra-long drug delivery.
Nanomaterials and UV light can “trap” chemicals for easy removal from soil and water.
An MIT faculty member since 1995, Hammond succeeds Klavs Jensen as ChemE department head.
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
New center will incorporate research on the study of aging in the Department of Biology, Picower Institute for Learning and Memory, and David H. Koch Institute for Integrative Cancer Research.
Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.